Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
India
/
Materials
Create a narrative
Epigral Community
NSEI:EPIGRAL Community
1
Narratives
written by author
0
Comments
on narratives written by author
1
Fair Values set
on narratives written by author
Create a narrative
Epigral
Popular
Undervalued
Overvalued
Community Investing Ideas
Epigral
AN
AnalystConsensusTarget
Consensus Narrative from 1 Analyst
New Expansions In CPVC And ECH Will Diversify Revenue Streams And Strengthen Market Position
Key Takeaways Expansion projects and new value chains are likely to boost revenue and earnings, enhancing diversity and capacity utilization by the end of FY '27. Focusing on domestic demand and international markets, Epigral aims to improve net margins through value-added import substitutes and integrated CapEx investments.
View narrative
₹2.30k
FV
22.4% undervalued
intrinsic discount
21.15%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
4 days ago
author updated this narrative
Your Valuation for
EPIGRAL
EPIGRAL
Epigral
Your Fair Value
₹
Current Price
₹1.78k
12.0% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
0
61b
2015
2018
2021
2024
2025
2027
2030
Revenue ₹60.8b
Earnings ₹8.6b
Advanced
Set Fair Value